| Symbol | Company | Weighting |
|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP USD | 5.17% |
| AKRO | AKERO THERAPEUTICS INC | 4.55% |
| ITCI | INTRA-CELLULAR THERAPIES USD | 3.17% |
| ARGX | ARGENX SE ADR | 2.70% |
| NTRA | NATERA INC | 2.66% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2.53% |
| ISRG | INTUITIVE SURGICAL INC | 2.41% |
| TARS | TARSUS PHARMACEUTICALS | 2.30% |
| BSX | BOSTON SCIENTIFIC | 2.21% |
| ALKS | ALKERMES INC | 2.08% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 2.03% |
| NUVL | NUVALENT INC | 1.94% |
| SYK | STRYKER CORP | 1.91% |
| LNTH | LANTHEUS HOLDINGS INC | 1.85% |
| PCVX | VAXCYTE INC | 1.85% |
| MCK | MCKESSON CORP | 1.82% |
| RNA | AVIDITY BIOSCIENCES INC | 1.81% |
| DNLI | DENALI THERAPEUTICS INC. | 1.80% |
| SNY | SANOFI- AVENTIS- ADR | 1.76% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.76% |
| EXAS | EXACT SCIENCES CORP | 1.74% |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.71% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.70% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.69% |
| UNH | UNITEDHEALTH GROUP INC | 1.65% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.64% |
| HCA | HCA HOLDINGS INC | 1.63% |
| BDX | BECTON DICKINSON & CO | 1.62% |
| ZTS | ZOETIS INC | 1.56% |
| AZN | ASTRAZENECA PLC-ADR | 1.43% |
| AVTR | AVANTOR, INC. | 1.41% |
| LLY | ELI LILLY CORP | 1.41% |
| IDXX | IDEXX LABS CORP | 1.40% |
| AMGN | AMGEN CORP | 1.40% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.38% |
| SRPT | SAREPTA THERAPEUTICS INC | 1.38% |
| IONS | IONIS PHARMACEUTICALS INC | 1.37% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.34% |
| CYTK | CYTOKINETICS INC | 1.32% |
| EW | EDWARDS LIFESCIENCES CORP | 1.30% |
| DHR | DANAHER CORP | 1.30% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.30% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.27% |
| XNCR | XENCOR INC. | 1.24% |
| TNDM | TANDEM DIABETES CARE INC | 1.23% |
| ELV | ELEVANCE HEALTH INC | 1.21% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.18% |
| REGN | REGENERON PHARMACEUTICALS | 1.17% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.14% |
| APLS | APELLIS PHARMACEUTICALS INC | 1.12% |
| IMVT | IMMUNOVANT INC | 1.10% |
| ACHC | ACADIA HEALTHCARE CO INC | 1.10% |
| MRK | MERCK & CO. NEW | 1.09% |
| DXCM | DEXCOM INC | 1.06% |
| NVO | NOVO NORDISK A/S | 1.00% |
| BIIB | BIOGEN INC | 0.95% |
| ARVN | ARVINAS INC USD | 0.89% |
| DYN | DYNE THERAPEUTICS, INC. | 0.86% |
| VKTX | VIKING THERAPEUTICS, INC. | 0.77% |
| KURA | KURA ONCOLOGY INC | 0.65% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.